Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FDAnews Announces -- EU-Medical Device Regulation and In Vitro Diagnostics Regulation Compliance Part I: EU-MDR Implementation Virtual Conference, Sept. 29, 2020
  • USA - English

Devicemakers: It's time to act and plan. EU-MDR compliance starts in May 2021. Not ready? No worries, just attend this…


News provided by

FDAnews

Sep 08, 2020, 13:00 ET

Share this article

Share toX

Share this article

Share toX

WCG FDAnews
WCG FDAnews

FALLS CHURCH, Va., Sept. 8, 2020 /PRNewswire-PRWeb/ -- EU-Medical Device Regulation and In Vitro Diagnostics Regulation Compliance: Virtual Workshop Series
Presented by FDAnews and Ombu Enterprises
Tuesday, Sept. 29, 2020: EU-MDR Implementation
Tuesday, Oct. 27, 2020: EU-IVDR Implementation
Wednesday, Nov. 4, 2020: Post-Market Activities for the EU-MDR and EU-ICDR
Tuesday, Nov. 10, 2020: Auditing EU-MDR and EU-IVDR Implementation
All sessions are held from 10:00 a.m.-4:30 p.m. ET.
https://www.fdanews.com/eumdrworkshopseries

Join us for one, two, three or four productive days of hands-on virtual training.

The EU-MDR compliance clock is ticking. Legacy products marketed in the EU are at serious risk unless one acts now. Many devicemakers still aren't ready for May 2021 set date. The transition is one complicated set of rules!

With one extension already granted, any organization selling devices in the region now needs to be ready by the May 2021 set date. There's little time to spare to get the processes up to par. There is still hope to align manufacturing with these expectations. While it may be impossible to fully meet the EU-MDR or EU-IVDR, learn how to remain compliant.

Mark the calendar for one, two, three, or four productive, exciting days of hands-on sessions with Dan O'Leary, a renowned regulatory and training specialist. Receive detailed checklists on device classifications, the application of Annex I, and internal quality audits, along with a workbook on UDI implementation.

We'll begin the workshop with a session on EU-MDR Implementation on Tuesday, September 29 from 10:00 a.m. to 4:30 p.m. Attendees will have the opportunity to dig deep into EU-MDR requirements and how a team can move toward full implementation. We'll cover:

  • Article 120: Transitioning into the EU-MDR through timeline concerns
  • QMS Implementation: Article 10(9) requirements and other QMS elements
  • Device Implementation: Annexes I, II, III, VIII and Article 52
  • Notified Body Interactions: Conformity assessment, notified body technical document review, and notified body on-site audits

Continue with us on Tuesday, October 27, and learn about EU-IVDR Implementation. While the date for these requirements isn't until May 2022, the time to get started on these changes is now. Join us for this session, and we'll cover:

  • Article 110: Transitioning into the EU-IVDR through timeline concerns
  • QMS Implementation: Article 10(8) requirements and QMS elements
  • Device Implementation: Annex I, II, III, VIII and Article 48
  • Notified Body Interactions: Conformity assessment, notified body technical document review, and notified body on-site audits

After the knowledge gained from the first two sessions (or if one is already an expert), join us for our third session on Post-Market Activities for the EU-MDR and EU-IVDR on Wednesday, November 4. We'll discuss:

  • Pre-Market Considerations: Clinical evaluation and performance, risk management and determination, and pre-market indicators and thresholds
  • Market Surveillance: Market and post-market surveillance; clinical follow-up
  • Post-Market Performance Follow-Up and SSCP
  • Vigilance and Trend Analysis

In our fourth and final session, we'll discuss Auditing EU-MDR and EU-IVDR Implementation on Tuesday, November 10. We'll share insights on the importance of good project management methods, including those around:

  • Internal Audit Programming: ISO 19011:2018 and 13485:2016
  • Conformity Assessment Paths and Device-Specific Areas: QMS and RMS; Annex I, II, and III
  • Applications to Notifying Bodies
  • Notifying Body Approach to Audits

The deadlines for these new regulations are approaching quickly. Don't miss this chance to gain expert advice on what can become a complicated, difficult and long process —and do it all from the comfort of one's own home.

Virtual Conference Details:
EU-Medical Device Regulation and In Vitro Diagnostics Regulation Compliance: Virtual Workshop Series
Presented by FDAnews and Ombu Enterprises
Tuesday, Sept. 29, 2020: EU-MDR Implementation
Tuesday, Oct. 27, 2020: EU-IVDR Implementation
Wednesday, Nov. 4, 2020: Post-Market Activities for the EU-MDR and EU-ICDR
Tuesday, Nov. 10, 2020: Auditing EU-MDR and EU-IVDR Implementation
All sessions are held from 10:00 a.m.-4:30 p.m. ET.
https://www.fdanews.com/eumdrworkshopseries

Tuition:
Part I: $587 per site
Part II: $587 per site
Part III: $587 per site
Part IV: $587 per site
Complete Series: $1,672

Easy Ways to Register:
Online: https://www.fdanews.com/eumdrworkshopseries
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

SOURCE FDAnews

Related Links

http://www.fdanews.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.